Our strategy is to become a pure-play Innovative Medicines company. We want to be the most valued and trusted, not just valued in terms of market capitalization, but also in the contributions we make with the medicines we produce for patients.
This video extract describes how we move faster with prioritization of high-value assets and additional investment in more indications.
Media Event: Event Date: February 1, 2023
Learn more: bit.ly/40tA16v
Novartis Strategy: bit.ly/3AjwVai
Disclaimer: Investor Relations events contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: bit.ly/3Asr96w
Follow @Novartis on Twitter: / novartis
Follow Novartis on LinkedIn: / novartis